1,030 results on '"Tuan, Ta-Chuan"'
Search Results
102. R2CHADS2 Score and Thromboembolic Events After Catheter Ablation of Atrial Fibrillation in Comparison With the CHA2DS2-VASc Score
103. Atrial fibrillation influences survival in patients with hepatocellular carcinoma: Experience from a single center in Taiwan
104. Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan
105. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study
106. Novel electrophysiological criteria for septal ventricular outflow tract tachycardias requiring a sequential bilateral ablation
107. Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation — Could it refine clinical risk stratification in AF?
108. Prevalence, Incidence, Lifetime Risks, and Outcomes of Heart Failure in Asia
109. Clinical outcomes and structural remodelling after ablation of atrial fibrillation in heart failure with mildly reduced or mid‐range ejection fraction
110. Catheter Ablation in Arrhythmic Cardiac Diseases: Endocardial and Epicardial Ablation
111. Alteration of Skin Sympathetic Nerve Activity after Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation
112. The association between hyperuricemia, left atrial size and new-onset atrial fibrillation
113. CHADS2 score and risk of new-onset atrial fibrillation: A nationwide cohort study in Taiwan
114. The association between the use of non-steroidal anti-inflammatory drugs and atrial fibrillation: A nationwide case–control study
115. Permanent Pacemaker Implantation for Late Atrioventricular Block in Patients Receiving Catheter Ablation for Atrioventricular Nodal Reentrant Tachycardia
116. Transforming growth factor-β1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation
117. Electrocardiographic features of failed and recurrent right ventricular outflow tract catheter ablation of idiopathic ventricular arrhythmias
118. Risk of Stroke in Patients With Short-Run Atrial Tachyarrhythmia
119. The roles of alcohol dehydrogenase in patients with atrial fibrillation
120. Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation—The potential role beyond the CHA2DS2-VASc score
121. Relationship between the CHADS2 score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation
122. The clinical and electroanatomical characteristics of paroxysmal lone atrial fibrillation
123. Sinus Node Dysfunction after Successful Atrial Flutter Ablation during Follow-Up: Clinical Characteristics and Predictors
124. PO-664-03 A NOVEL PREDICTOR OF EPICARDIAL BREAKTHROUGH DURING CATHETER ABLATION OF PERIMITRAL ATRIAL FLUTTER
125. PO-706-06 A DEEP LEARNING-ENABLED ELECTROCARDIOGRAM MODEL FOR THE IDENTIFICATION OF PRESENCE OF ATRIAL FIBRILLATION DURING SINUS RHYTHM
126. PO-06-109 DISTINCTIVE ELECTROGRAM FEATURES IN SUCCESSFUL ABLATION SITES FOR VENTRICULAR ARRHYTHMIAS ARISING FROM THE VICINITY OF LEFT VENTRICULAR SUMMIT
127. PO-05-005 MICRORNA-122'S PROTECTIVE EFFECTS ON LEFT ATRIAL SUBSTRATE: CLINICAL AND MITOCHONDRIAL PERSPECTIVES
128. PO-03-011 CLINICAL IMPLEMENTATION OF 3D DEEP LEARNING TECHNIQUES IN PREDICTING TOUCH-UP LESIONS FOR ATRIAL FIBRILLATION PATIENTS UNDERGOING CRYOABLATION
129. PO-03-141 LONGITUDINAL OUTCOMES OF ABLATION THERAPY FOR PAROXYSMAL ATRIAL FIBRILLATION IN ASIAN POPULATIONS WITH METABOLICALLY DISTINCT OBESITY PROFILES
130. MP-470546-003 SIGNAL-AVERAGED ELECTROCARDIOGRAPHY AS A NONINVASIVE TOOL FOR EVALUATING THE VENTRICULAR SUBSTRATE IN PATIENTS WITH NONISCHEMIC CARDIOMYOPATHY: REASSESSMENT OF AN OLD TOOL
131. Associations among the CHADS 2 score, atrial substrate properties, and outcome of catheter ablation in patients with paroxysmal atrial fibrillation
132. The correlation between ventricular repolarization and clinical severity of spinal cord injuries
133. Impact of circulating monocyte CD36 level on atrial fibrillation and subsequent catheter ablation
134. Gender differences of electrophysiologic characteristics in patients with accessory atrioventricular pathways
135. Quantitative Analysis of Quantity and Distribution of Epicardial Adipose Tissue Surrounding the Left Atrium in Patients With Atrial Fibrillation and Effect of Recurrence After Ablation
136. Application of Ensite™ LiveView function for identification of scar‐related ventricular tachycardia isthmus
137. Early Rhythm Control and the Risks of Ischemic Stroke, Heart Failure, Mortality, and Adverse Events When Performed Early (<3 Months): A Nationwide Cohort Study of Newly Diagnosed Patients with Atrial Fibrillation
138. Using QRS loop descriptors to characterize the risk of sudden cardiac death in patients with structurally normal hearts
139. An observational study on the effect of premature ventricular complex burden on long-term outcome
140. Left Atrial Size and Left Ventricular End‐Systolic Dimension Predict the Progression of Paroxysmal Atrial Fibrillation After Catheter Ablation
141. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study
142. Response by Chao et al to Letters Regarding Article, “Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage”
143. Clinical outcomes and structural remodelling after ablation of atrial fibrillation in heart failure with mildly reduced or mid‐range ejection fraction.
144. Atrial Substrate Properties and Outcome of Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation Associated With Diabetes Mellitus or Impaired Fasting Glucose
145. Prognostic Implications of the High-Sensitive C-Reactive Protein in the Catheter Ablation of Atrial Fibrillation
146. Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation
147. Long-term mortality and cardiovascular outcomes in patients with atrial flutter after catheter ablation
148. Role of the right atrial substrate in different types of atrial arrhythmias
149. Electrophysiologic characteristics and catheter ablation of focal atrial tachycardia with more than one focus
150. Comparison of Outcome in Catheter Ablation of Atrial Fibrillation in Patients With Versus Without the Metabolic Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.